A six-year-old boy with hypohydrotic ectodermal dysplasia, immunodeficiency and a novel mutation in the nuclear factor kappa B essential modulator (NEMO) gene
Keep a written log of your reconstitution date, water volume used, and resulting concentration
Sermorelin's FDA Journey: Approved, Discontinued, and Compounded Sermorelin acetate (Geref) was FDA-approved in 1997 for pediatric GHD 1 and in 1990 for diagnostic use.26 The manufacturer discontinued Geref in 2008 due to "manufacturing difficulties," not safety or efficacy concerns.12 In 2013, the FDA confirmed it wasn't withdrawn for safety/effectiveness, allowing for potential generic approvals.12 Currently, Sermorelin is primarily available as a compounded medication 3, which is permitted but not individually FDA-approved like mass-produced drugs.22 5.2
Studies have used MT-II alongside MC4R-selective agonists and MC4R knockout models to attribute the anorectic component of MT-IIs biology specifically to MC4R rather than MC3R activation
Our holistic approach respects your hormones, hunger, and mental well-being, blending science with functional wellness for results that last
